Ignite Creation Date:
2024-05-05 @ 11:59 AM
Last Modification Date:
2024-10-26 @ 9:18 AM
Study NCT ID:
NCT00202475
Status:
COMPLETED
Last Update Posted:
2009-10-20
First Post:
2005-09-13
Brief Title:
Collection of Autologous Blood Products by Double Erythrocytapheresis
Sponsor:
Sanquin Research Blood Bank Divisions
Organization:
Sanquin Research Blood Bank Divisions
Study Overview
Official Title:
Collection of Autologous Blood Products by Double Erythrocytapheresis - Cost Effectiveness Study
Status:
COMPLETED
Status Verified Date:
2009-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The project will determine the advantages of double erythrocytapheresis in the collection of preoperative autologous erythrocytes as compared to the standard collections of whole blood The study will assess the total reduction in the number of procedures required to obtain the preoperative units ordered by the surgeon Also successfulness of erythrocytaphereses versus classical whole blood collection for these patients will be compared
Detailed Description:
The project will determine the advantages of double erythrocytapheresis in the collection of preoperative autologous erythrocytes as compared to the standard collections of whole blood The study will assess the total reduction in the number of procedures required to obtain the preoperative units ordered by the surgeon Also successfulness of erythrocytaphereses versus classical whole blood collection for these patients will be compared
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None